Shedding of Epstein-Barr virus (EBV) into saliva was studied in 31 patients with verified acute infectious mononucleosis. The patients had been randomized for intravenous treatment with acyclovir (ACV) at 10 mg/kg body weight at 8 h intervals for 7 days, or placebo, in a double-blind trial. EBV in centrifuged throat washings was detected by transformation of umbilical cord lymphocytes and by immunofluorescence staining for EBV-associated nuclear antigen in fixed cell smears. Saliva samples were obtained before and during treatment, and after 4 weeks and 6 months, respectively. ACV effectively but transiently interrupted EBV production (P < 0.001), but virus shedding resumed at the initial level within 3 weeks of cessation of the treatment. Initially, 93.5% of the patients had detectable EBV in the saliva compared with 83% in the 4th week and 58% after 6 months.
ColbyB.,
ShawJ.,
DattaA.,
PaganoJ.1982; Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir. American Journal of Medicine 73:77–81
DattaA. K.,
ColbyB. M.,
ShawI. E.,
PaganoJ. S.1980; Acyclovir inhibition of Epstein-Barr virus replication. Proceedings of the National Academy of Sciences, U.S.A 77:5163–5166
De MirandaP.,
BlumM. R.1983; Pharmakokinetics of acyclovir after intravenous and oral administration. Journal of Antimicrobial Chemotherapy 12: supplement B 29–37
ElionG.,
FurmanP.,
FyfeJ.,
De MirandaP.,
BeauchampL.,
SchafferH.1977; Selectivity of action of an antiherpetic agent, 9-(2-hydroxy ethoxymethyl)guanine. Proceedings of the National Academy of Sciences, U.S.A. 74:5716–5720
FurmanP. A.,
St ClairM. H.,
FyfeJ. A.,
RideoutJ. L.,
KellerP. M.,
ElionG. B.1979; Inhibition of herpes simplex virus induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxy ethoxymethyl) guanine and its triphosphate. Journal of Virology 32:72–77
GerberP.,
LucasS.,
NonoyamaM.,
PerlinE.,
GoldsteinL.1972; Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet ii:988–989
GreenspanJ. S.,
GreenspanD.,
LennetteE.,
AbramsD. L.,
ConantM. A.,
PetersenV.,
FreeseK.1985; Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313:1564–1571
LinJ.,
SmithC.,
PaganoJ.1984; Prolonged inhibitory effect of 9(l, 3-dihydroxy-2-propoxy methyl)guanine against replication of Epstein-Barr virus. Journal of Virology 50:50–55
MillerG.,
LipmanM.1973; Comparison of yield of virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. Journal of Experimental Medicine 138:1398–1411
MillerG.,
NiedermanJ.,
AndrewsB.1973; Prolonged oropharyngeal excretion of Epstein-Barr virus infectious mononucleosis. New England Journal of Medicine 288:229–232
NiedermanJ.,
MillerG.,
PearsonG.,
PaganoI.,
DowalibyJ.1976; Infectious mononucleosis: Epstein-Barr virus shedding in the saliva and the oropharynx. New England Journal of Medicine 294:1355–1359
ReedmanB.,
KleinG.1973; Cellular localization of an Epstein-Barr virus associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–523
SchaefferH. J.,
BeauchampL.,
De MirandaP.,
ElionG. B.,
BauerD. J.,
CollinsP.1978; 9-(2-hydroxy ethoxymethyl)guanine activity against viruses of the herpes group. Nature, London 272:583–585
SixbeyI.,
NedrudJ.,
Raab-TraubM.,
HanesR.,
PaganoJ.1984; Epstein-Barr virus in oropharyngeal epithelial cells. New England Journal of Medicine 310:1225–1234
SullivanJ.,
MedveczkyP.,
FormanS.,
BakerS.,
MonroeJ.,
MulderC.,
PhilD.1984; Epstein-Barr virus induced lymphoproliferation: implications for antiviral chemotherapy. New England Journal of Medicine 311:1163–1167
YaoQ. Y.,
RickinsonA. B.,
EpsteinM. A.1985; A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35:35–42
ZerbiniM.,
ErnbergL.1983; Can Epstein-Barr virus infect and transform all the B-lymphocytes of human cord blood?. Journal of General Virology 64:539–547